Poster 1
The role of oral antibiotics in the treatment of mild to moderate hidradenitis suppurativa
top of page
DERM2022 POSTERS
We invite you to view the DERM2022 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.
Poster 2
An Updated Reference for Empiric Antibiotic Therapy in Hidradenitis Suppurativa
56 views
Poster 3
Efficacy and Safety of a Fixed-Dose Clindamycin 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized
32 views
Poster 4
Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Tolerability, and Spreadability
19 views
Poster 5
Efficacy of 1% clascoterone cream through up to 12 months from a long-term extension study in patients ≥9 years of age with acne vulgaris
17 views
Poster 6
Trifarotene 0.005% Cream: A Case Series of Five Subjects with Skin of Color
14 views
Poster 7
Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide
12 views
Poster 8
Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea
12 views
Poster 9
A New Frontier in Acne Treatment: Encapsulated Benzoyl Peroxide and Tretinoin
12 views
Poster 10
Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING
16 views
Poster 11
Racial and Ethnic Differences in Sociodemographic and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States:
9 views
Poster 12
Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-C
7 views
Poster 13
Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis...
4 views
Poster 14
Post-hoc Analyses of Lebrikizumab Phase 3 Trials (LAVOLTA I and II): Enhanced Efficacy in Patients with Prior Exacerbations and Elevated...
5 views
Poster 15
Lebrikizumab Allows Interleukin (IL)-13 Membrane Binding and Subsequent Internalization through IL-13 Receptor Alpha 2 (Ra2) [IL-13 decoy...
8 views
Search by
Poster
Number
bottom of page